Call to ActionClinical diagnosis of endometriosis: a call to action
Key words
Cited by (0)
S.K.A. is a consultant for and has received research support from AbbVie. C.C. is consultant for Ipsen, Bayer, AbbVie, and Gedeon Richter. He is an advisor/consultant for AbbVie, Bayer, Ipsen, and Gedeon Richter Preglem. L.C.G. is a consultant for AbbVie, Myovant Sciences, ForEndo Pharma, NextGen Jane, and Merck. M.R.L. is a consultant for AbbVie and NextGen Jane. N.L. is a consultant for and has received research support from AbbVie, Allergan, and the Canadian Institutes for Health Research. S.A.M. is a consultant for AbbVie, Oratel Diagnostics, and Celmatix, and receives research support from the National Institutes of Health and the Marriott Family Foundations. S.S.S. is a consultant for and has received research support from AbbVie, Bayer, and Allergan. H.S.T. is a consultant for AbbVie, Bayer, Obseva, OvaScience, ForEndo, and DotLab.
Support for the development of this manuscript was provided by AbbVie, Inc. AbbVie had the opportunity to review the final manuscript draft, but the manuscript content was solely at the discretion of the authors and reflects the opinions of the authors. The authors received no direct compensation for their efforts.